Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NVS compared with TAK: revenue, margins and what each company keeps, and the suppliers and customers both name
NVS
Novartis AG
Change
Mkt cap
Revenue
Revenue
TAK
Takeda Pharmaceutical Co Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
NVS
Novartis AG
vs
TAK
Takeda Pharmaceutical Co Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
NVS: latest quarter not drawable. TAK: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NVS
21
REGN
Regeneron Pharmaceuticals
supplier
VEEV
Veeva Systems
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
PTCT
PTC Therapeutics
supplier
17 more · NVS chain
›
Shared
0
No shared counterparties.
Only TAK
17
NBIX
Neurocrine Biosciences
customer
EXEL
Exelixis
supplier
PTGX
Protagonist Therapeutics
supplier
DNLI
Denali Therapeutics
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
13 more · TAK chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NVS, solid
TAK, dashed
NVS
Novartis AG
Change
165.69
▲
+0.43%
Mkt cap
$314.8B
TAK
Takeda Pharmaceutical Co Ltd
Change
21.68
▲
+2.94%
Regular session
Nov 5 '26
Mkt cap
$36.3B
vs
Compare
Regular session
Nov 5 '26
NVS
Novartis AG
vs
TAK
Takeda Pharmaceutical Co Ltd
165.69
▲
+0.43%
Price
21.68
▲
+2.94%
$314.8B
Mkt cap
$36.3B
Change
Change
NVS
165.69
▲
+0.43%
vs
TAK
21.68
▲
+2.94%
Regular session
Nov 5 '26